061 - Bacille Calmette-Guérin (BCG) vaccine induces distinct shifts in the human newborn monocyte metabolome in vitro and peripheral blood plasma in vivo: Implications for neonatal trained immunity

Asimenia Angelidou, Harvard Medical School, Boston, MA, United States; Caitlin Syphurs, Boston Children's Hospital, Boston, MA, United States; Jing Chen, Boston Children's Hospital, Boston, MA, United States; Eva Illuzzi, Boston Children's Hospital, Brookline, MA, United States; Tobias R. Kollmann, Dalhousie University, Halifax, NS, Canada; Jessica Lasky-Su, Brigham and Women's Hospital, Boston, MA, United States; Simon D.. van Haren, Boston Children's Hospital, Boston, MA, United States; Ofer Levy, Precision Vaccines Program, Boston Children's Hospital, Boston, MA, United States; Joann Diray-Arce, Harvard Medical School, Boston, MA, United States; Olubukola T. Idoko, LSHTM, Lyon, Rhone-Alpes, France